Taylor Sandison
Directeur Technique/Scientifique/R&D chez CIDARA THERAPEUTICS, INC.
Fortune : 139 831 $ au 31/05/2024
Postes actifs de Taylor Sandison
Sociétés | Poste | Début | Fin |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2017 | - |
Historique de carrière de Taylor Sandison
Anciens postes connus de Taylor Sandison
Sociétés | Poste | Début | Fin |
---|---|---|---|
MERCK & CO., INC. | Directeur Technique/Scientifique/R&D | 01/02/2015 | 01/10/2015 |
CUBIST PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/07/2014 | 01/02/2015 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/04/2013 | 01/06/2014 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Directeur Technique/Scientifique/R&D | 01/09/2010 | 01/03/2013 |
Formation de Taylor Sandison
Dartmouth College | Undergraduate Degree |
University of Washington | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CIDARA THERAPEUTICS, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
- Bourse
- Insiders
- Taylor Sandison
- Expérience